Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Elution in Total Knee Arthroplasty
NCT03928522Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2019
- Primary completion
- Sep 2019
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tobramycin and vancomycin in prosthetic joint infection (PJI) (4 arms), sponsored by Washington University School of Medicine. Primary endpoint: Amount of Vancomycin and Tobramycin Eluted From Hand Mixed Cement With Both Antibiotics After Total Knee Arthroplasty at 24 hours. Started Jan 2019; status: completed.
02
Drugs
tobramycinvancomycin
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT03928522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03928522.